Yoko Ushijima Selected Research

Yoko Ushijima Research Topics

3	Neoplasms (Cancer) 01/2023 - 01/2016
3	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 08/2017
3	Infections 11/2011 - 10/2007
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2023 - 05/2021
2	Epstein-Barr Virus Infections 11/2011 - 03/2008
1	Hepatitis 05/2021
1	Acute Promyelocytic Leukemia 01/2018
1	Hematologic Neoplasms (Hematological Malignancy) 08/2017
1	Heart Failure 01/2017
1	Cardiac Arrhythmias (Arrythmia) 01/2017
1	Neutropenia 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Exanthema (Rash) 01/2016
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2016
1	Anemia 01/2016
1	Sepsis (Septicemia) 01/2016
1	Nasopharyngitis 01/2016
1	Lymphoma (Lymphomas) 11/2011

1	Chimeric Antigen ReceptorsIBA 01/2023
1	tisagenlecleucelIBA 01/2023
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 05/2021
1	lipoarabinomannan (LAM)IBA 05/2021
1	Rituximab (Mabthera)FDA Link 05/2021
1	Alanine Transaminase (SGPT)IBA 05/2021
1	Surface Antigens (Surface Antigen)IBA 05/2021
1	Antiviral Agents (Antivirals)IBA 05/2021
1	DNA (Deoxyribonucleic Acid)IBA 05/2021
1	Arsenic Trioxide (Trisenox)FDA Link 01/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Tacrolimus (Prograf)FDA LinkGeneric 08/2017
1	fludarabineIBA 08/2017
1	Methotrexate (Mexate)FDA LinkGeneric 08/2017
1	HLA-A Antigens (HLA-A)IBA 08/2017
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 08/2017
1	SteroidsIBA 01/2017
1	BilirubinIBA 01/2016
1	ibrutinibIBA 01/2016
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2016
1	Proteasome InhibitorsIBA 11/2011
1	Bortezomib (Velcade)FDA Link 11/2011
1	Messenger RNA (mRNA)IBA 04/2008
1	OligonucleotidesIBA 03/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 03/2008
1	Connexin 43 (Connexin43)IBA 10/2007
1	Proteins (Proteins, Gene)FDA Link 10/2007